Vittorio Ruggero Zilioli

15PUBLICATIONS

110CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jul 14, 2026

Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Jun 08, 2026

Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial.

|May 04, 2026

Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial.

|Dec 30, 2025

Secondary Genetic Events and Their Relationship to <i>TP53</i> Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo

|Dec 10, 2025

The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE-FIRST study.

Francesca Maria Quaglia, Annalisa Arcari, Lucia Morello

|May 13, 2025

Comparative Effectiveness of R-miniCOMP Versus R-miniCHOP in Older Non-Fit Patients With Diffuse Large B-Cell Lymphoma: Insights From a "Fondazione Italiana Linfomi" Cohort Study.

Alberto Bavieri, Sara Veronica Usai, Michele Merli

Pageof 3

Frequent Collaborators

Federica Cavallo

Stefano Luminari

Alessandro Re

Francesco Merli

Alessandra Tucci

Annalisa Arcari

Luca Arcaini

Rita Tavarozzi

Jacopo Olivieri

Donato Mannina

Frequent Collaborators

Federica Cavallo

Stefano Luminari

Alessandro Re

Francesco Merli